Related Experiment Videos
Unusual manifestations of B-cell disorders. Case 1: multiple myeloma with predominant phalangeal involvement
1Cerrahpasa School of Medicine, Istanbul University, Turkey.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.
Actas urologicas espanolas·2024
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Surgery and tile-based radiation therapy versus surgery and stereotactic radiation for newly diagnosed brain metastases (ROADS): a randomized, open-label, phase 3 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
When Survival Separates.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Transcriptomic Plasticity and Its Spatial Architecture Shape Melanoma Response to Immunotherapy and Its Combination With BRAF/MEKi.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
How to Do a Laparoscopic Iliac Lymph Node Biopsy Under Indocyanine Green (ICG) Guidance.
ANZ journal of surgery·2026
Refrigerated storage stability of 11 humoral parameters in two different venous blood collection tubes over a 7-day period.
Clinical chemistry and laboratory medicine·2026
Ultrasensitive quantification links higher serum interferon-α and interferon-γ levels with lower leukocyte and lymphocyte counts in lupus.
Rheumatology (Oxford, England)·2026
Prevalence of A2 and A2B Blood Group Subgroups Among Blood Donors in Al-Qurayyat, Saudi Arabia: A Cross-Sectional Study.
Annals of clinical and laboratory science·2026
Knowledge, attitudes, and practices related to bovine tuberculosis in Benin: a mixed One Health survey among farmers, veterinarians, and butchers.
One health (Amsterdam, Netherlands)·2026
Dynamics of Borrelial Antibodies in European Lyme Borreliosis Patients with Erythema Migrans.
Medical sciences (Basel, Switzerland)·2026